Daiichi Pharmaceutical Acquires Daiichi Suntory Pharma As Wholly Owned Subsidiary.Tokyo, Japan, Sept 16, 2005 - (JCNN JCNN Japan Corporate News Network ) - Daiichi Pharmaceutical acquired Daiichi Suntory Pharma, a joint venture it had created with Suntory in December 2002, as a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. on September 1. Daiichi Pharmaceutical agreed to purchase Suntory's 34% stake in the joint venture for 20 billion yen ($180 mil An Internet address domain name for a military agency. See Internet address. (networking) mil - The top-level domain for entities affiliated with US armed forces. ) as of September 27 in its attempt to strengthen the subsidiary's financial strength. In addition, Daiichi Pharmaceutical will establish Daiichi Sankyo, a joint holding company with Sankyo, as of October 1. Accordingly, Daiichi Suntory will change its name to Daiichi Asbio Pharma. Source: JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion